1. Stohs SJ, Ji J, Bucci LR, Preuss HG. 2017. A Comparative Pharmacokinetic Assessment of a Novel Highly Bioavailable Curcumin Formulation with 95% Curcumin: A Randomized, Double-blinded, Crossover Study. J Am Coll
Nutr.doi: 10.108007315724.2017.1358168.
Amalraj A, Pius A, Gopi S, Gopi S. 2017. Biological activities of curcurninoids, other molecules from turmeric and their derivatives-a review. J Trad Compl Med. 7; 205-233;
Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, Prasad S, Aggarwal BB. 2017. Curcumin, the golden nutraceutical: multi-targeting for multiple chronic diseases. Br J Pharmacol. 174; 1325-1348;
Pulido-Moran M, Moreno-Fernandez J, Ramirez-Tortosa C, Ramirez-Tortosa CM. Curcumin and health. 2016. Molecules 21; 264. doi. 10.3390/molecules-21030264;o Kocaadam B, Sanlier N. 2015. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit Rev Food Sci Nutr. doi. 10.1080/10408398.2015.1077195;
Panahi Y, Khalili N, Namazi S, Karimian MS, Majeed M, Sahebkar A. 2017. Antioxidant effects of curcuminoids in patients with type two diabetes mellitus: a randomized controlled trial. Inflammopharmacol. 25; 25-31; and
DiSilvestro RA, Joseph E, Zhao S, Bomser J. 2012. Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. Nutr J. 11; 79. doi: 10.1186/1475-2891-11-79.
2. S.J. Stohs, J. Ji, L.R. Bucci, H.G. Preuss. 2018 A comparative pharmacokinetic assessment of a novel highly bioavailable curcumin formulation with 95 % curcumin: a randomized, double-blind, cross-over study. J Am. Coll. Nutr. 37; 51-59.
S.J. Stohs, S.D. Ray. 2019. Issues with human bioavailability determinations of bioactive curcumin. Biomed. J. Sci. Tech. Res. doi.10.26717/BJSTR.2019.12.002289.
S.J. Stohs, C.Y.O. Chen, H.G. Preuss, S.D. Ray, L.R. Bucci, J. Ji, K.J. Ruff. 2019. The fallacy of enzymatic hydrolysis for the determination of bioactive curcumin in plasma samples as an indicator of bioavailability: a comparative study. BMC Comp. Alt. Med. (in press).
S.J. Stohs, H.G. Preuss, J. Ji, C.Y.O. Chen, K.J. Ruff, S.D. Ray, L.R. Bucci, 2020. Curcumin pharmacokinetics and plasma determination. In: Chemistry of Bioactive Components of Turmeric. S. Gopi et al., editors. Royal Society of Chemistry, London. (in press).
3. Amalraj A, Pius A, Gopi S, Gopi S. 2017. Biological activities of curcuminoids, other molecules from turmeric, and their derivatives-a review. J Trad Compl Med. 7; 205-233;o Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, Prasad S, Aggarwal BB. 2017. Curcumin, the golden nutraceutical: multi-targeting for multiple chronic diseases. Br J Pharmacol. 174; 1325-1348;
Pulido-Moran M, Moreno-Fernandez J, Ramirez-Tortosa C, Ramirez-Tortosa CM. Curcumin and health. 2016. Molecules 21; 264. doi. 10.3390/molecules-21030264;
Kocaadam B, Sanlier N. 2015. Curcurnin, an active component of turmeric (Curcuma longa), and its effects on health. Crit Rev Food Sci Nutr. doi. 10.1080/10408398.2015.1077195;
Oliver JM, Stoner L, Rowlands DS, Caldwell AR, Sanders E, Kreutzer A, Mitchell JB, Purpura M, Jager R. 2016. Novel Form of Curcumin Improves Endothelial Function in Young, Healthy Individuals: A Double-Blind Placebo Controlled Study. J Nutr Metab. 2016:1089653. doi: 10.1155/2016/1089653; and
Funamoto M, Sunagawa Y, Katanasaka Y, Miyazaki Y, Imaizumi A, Kakeya H, Y amakage H, Satoh-Asahara N, Komiyama M, Wada H, Hasegawa K, Morimoto T. 2016. Highly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels in patients with mild COPD. Int J Chron Obstruct Pulmon Dis. 11 :2029-2034.
4. Amalraj A, Pius A, Gopi S, Gopi S. 2017. Biological activities of curcuminoids, other molecules from turmeric and their derivatives-a review. J Trad Compl Med. 7; 205-233;o Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, Prasad S, Aggarwal BB. 2017. Curcumin, the golden nutraceutical: multi-targeting for multiple chronic diseases. Br J Pharmacol. 174; 1325-1348;
Pulido-Moran M, Moreno-Fernandez J, Ramirez-Tortosa C, Ramirez-Tortosa CM. Curcumin and health. 2016. Molecules 21; 264. doi. 10.3390/molecules-21030264;
Kocaadam B, Sanlier N. 2015. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit Rev Food Sci Nutr. doi. 10.1080/10408398.2015.1077195;
Dulbecco P, Savarino V. 2013. Therapeutic potential
of curcumin in digestive diseases. Review. World J Gastroenterol 19; 9256- 9270;
Vecchi Brumatti L, Marcuzzi A, Tricarico PM, Zanin V, Girardelli M, Bianco AM. 2014. Curcumin and inflammatory bowel disease: potential and limits of innovative treatments. A review. Molecules 19; 21127-21153; ando Ali T, Shakir F, Morton J. 2012. Curcumin and inflammatory bowel disease: biological mechanisms and clinical implication. Review. Digestion 85; 249-55.
5. Daily JW, Yang M, Park S. 2016. Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: A systematic review and meta-analysis of randomized clinical trials. J Med Food 19; 717-729;o Belcaro G, Cesarone MR, Dugall M, Pellegrini L, Ledda A, Grossi MG, Togni S, Appendino G. 2010. Efficacy and safety of Meriva®, a curcuminphosphatidylcholine complex, during extended administration in osteoarthritis patients. Altera Med Rev. 15: 337-344;
Drobnic F, Riera J, Appendino G, Topgni S, Franceschi F, Valle X, Pons A, TurJ. 2014. Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva®): a randomized, placebo-controlled trial. J Int Soc Sports Nutr. 11:31. Doi:10.1186/1550-2015-ll-31;
Singla N, Desjardins PJ, Cosca EB, Parulan C, Arriaga A, Poole KC, Batz DM, Chang PF. 2015. Delayed-onset muscle soreness: a pilot study to assess analgesic study design features. Pain 156: 1036-1045;
Amalraj A, Varma K, Jacob J, Divya C, Kunnamakkara R, Stohs SJ, Gopi S. 2017. A novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled, two-dose, three-arm, and parallel-group study. J Funct Food 20: 1022-103,0;o Onakpoya IJ, Spencer EA, Perera R, Heneghan CJ. 2017. Effectiveness of curcuminoids in the treatment of knee osteoarthritis: a systematic review and meta-analysis ofrandomized clinical trials. Int J Rheum Dis. 20: 420-433;o Hewlings SJ, KalmanDS. 2017. Curcumin: a review of its effects on human health. Food 5:10. doi10.3390/foods6100092;
Di Pierro F, Settembre R. 2013. Safety and efficacy of an add-on therapy with curcumin phytosome and piperine and/or lipoic acid in subjects with a diagnosis of peripheral neuropathy treated with dexibuprofen. J. Pain Res. 6: 497-503; and
Di Pierro F, Rapacioli G, Di Maio EA, Appendino G, Franceschi F, Togni S. 2013. Comparative evaluation of the pain-relieving properties of a lecithinized formulation of curcumin (Meriva®), nimesulide, and acetaminophen. J. Pain Res. 6: 201-205.
6. Wu A, Noble EE, Tyagi E, Ying Z, Zhuang Y, Gomez-Pinilla F. 2015. Curcumin boosts DHA in the brain. Implications for the prevention of anxiety disorders. Biochim Biophys Acta 1852; 951-961;
Cox KH, Pipingas A, Scholey AB. 2015. Investigation of the effects of a solid lipid curcumin on cognition and mood in a healthy older population. 29; 642-651;
Pandaran Sudheeran S, Jacob D, Natinga Mulakal J, Gopinathan Nair G, Maliakel A, Maliakel B, Kuttan R, Im K. 2016. Safety, tolerance, and enhanced efficacy of a bioavailable formulation of curcumin with fenugreek dietary fiber on occupational stress: a randomized, double-blind, placebo-controlled pilot study. J Clin Psychopharmacol 36; 236-243; and
Adalier N, Parker H. 2016. Vitamin E, turmeric and saffron in treatment of Alzheimer's disease. Antioxidants 5; 40; doi: l0.3390//antiox/5040040.
